| Literature DB >> 24100128 |
John Ayuk1, Neil J L Gittoes2.
Abstract
Serum magnesium concentration is determined by the interplay of intestinal absorption and renal excretion. Hypomagnesemia can occur as a result of insufficient magnesium intake, increased gastrointestinal or renal loss, or redistribution from extracellular to intracellular compartments. A number of drugs are known to cause hypomagnesemia, including proton pump inhibitors (PPIs). We report the case of a patient with symptomatic hypomagnesemia due to short bowel syndrome and PPI therapy. Investigations revealed low 24-hour urinary magnesium excretion and secondary hypocalcemia. PPI treatment was withdrawn and the patient was managed with intravenous and oral magnesium and calcium replacement. This teaching case provides an evidence-based discussion of the treatment of hypomagnesemia.Entities:
Keywords: Hypomagnesemia; intravenous magnesium sulfate; oral magnesium salts; proton pump inhibitor; treatment
Mesh:
Substances:
Year: 2013 PMID: 24100128 DOI: 10.1053/j.ajkd.2013.07.025
Source DB: PubMed Journal: Am J Kidney Dis ISSN: 0272-6386 Impact factor: 8.860